Cylapril weight-loss claim halted
This article was originally published in The Tan Sheet
Executive Summary
The Electronic Retailing Self-Regulation Program recommends Adrenal Fatigue Institute discontinue claims that its supplement Cylapril helps consumers "lose the weight in just two easy steps," according to a June 24 report. The marketer failed to substantiate weight-loss claims during a routine review by ERSP. The firm agreed to discontinue the claims and claims that Cylapril is the "only product of its kind." The marketer supported claims that the supplement improves adrenal functioning, metabolism and fatigue, added ERSP